ISIN
DE000A3CMGM5
Ticker
APPH
Sector
Sub-Industry
Country
Germany
Year Founded
1946
APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single Pills combine two to three generic active ingredients in one combination preparation. APONTIS PHARMA develops, markets and distributes a broad portfolio of Single Pills and other medicines, with a particular focus on cardiovascular diseases. Since 2013, APONTIS has successfully launched several Single Pills solely for cardiovascular indications such as hypertension, hyperlipidaemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in the heart of Europe's strongest pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a target customer group of around 23,000 doctors in Germany.
168
Germany
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
14.05.2024 | Milz, Thomas | Board | Buy | EUR 8,960.00 |
14.05.2024 | be executive GmbH | Close relation | Buy | EUR 8,880.00 |
13.05.2024 | Zimmermann, Thomas | Other | Buy | EUR 10,128.00 |
13.05.2024 | Zimmermann, Thomas | Other | Buy | EUR 3,396.00 |
13.05.2024 | Zimmermann, Thomas | Other | Buy | EUR 1,692.00 |
13.05.2024 | Zimmermann, Thomas | Other | Buy | EUR 1,688.00 |
05.05.2023 | Reineke, Silke | Close relation | Buy | EUR 36,625.00 |
05.05.2023 | Milz, Thomas | Board | Buy | EUR 14,360.00 |
DE000A3CMGM5
894500ETO1J6MR8PDF91
Hauck AufhΓ€user Lampe Privatbank AG
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.